In Vitro Activity of Tedizolid Against Gram-Positive Bacteria in Patients With Skin and Skin Structure Infections and Hospital-Acquired Pneumonia: A Korean Multicenter Study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Yangsoon | - |
dc.contributor.author | Hong, Sung Kuk | - |
dc.contributor.author | Choi, SungHak | - |
dc.contributor.author | Weonbinlm | - |
dc.contributor.author | Yong, Dongeun | - |
dc.contributor.author | Lee, Kyungwon | - |
dc.date.accessioned | 2022-07-16T01:13:36Z | - |
dc.date.available | 2022-07-16T01:13:36Z | - |
dc.date.created | 2021-05-12 | - |
dc.date.issued | 2015 | - |
dc.identifier.issn | 2234-3806 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/158297 | - |
dc.description.abstract | We compared the activities of tedizolid to those of linezolid and other commonly used antimicrobial agents against gram-positive cocci recovered from patients with skin and skin structure infections (SSSIs) and hospital-acquired pneumonia (HAP) in Korean hospitals. Gram-positive isolates were collected from 356 patients with SSSIs and 144 patients with HAP at eight hospitals in Korea from 2011 to 2014. SSSIs included impetigo, cellulitis, erysipelas, furuncles, abscesses, and infected burns. Antimicrobial susceptibility was tested by using the CLSI agar dilution method. All of the gram-positive isolates were inhibited by <= 1 mu g/mL tedizolid. The minimum inhibitory concentration [MIC]₉₀ of tedizolid was 0.5 mu g/mL for methicillin-resistant Staphylococcus aureus, which was 4-fold lower than that of linezolid. Tedizolid may become a useful option for the treatment of SSSIs and HAP caused by gram-positive bacteria. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | KOREAN SOC LABORATORY MEDICINE | - |
dc.title | In Vitro Activity of Tedizolid Against Gram-Positive Bacteria in Patients With Skin and Skin Structure Infections and Hospital-Acquired Pneumonia: A Korean Multicenter Study | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Yangsoon | - |
dc.identifier.doi | 10.3343/alm.2015.35.5.523 | - |
dc.identifier.scopusid | 2-s2.0-84942255217 | - |
dc.identifier.wosid | 000358819400008 | - |
dc.identifier.bibliographicCitation | ANNALS OF LABORATORY MEDICINE, v.35, no.5, pp.523 - 530 | - |
dc.relation.isPartOf | ANNALS OF LABORATORY MEDICINE | - |
dc.citation.title | ANNALS OF LABORATORY MEDICINE | - |
dc.citation.volume | 35 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 523 | - |
dc.citation.endPage | 530 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002013449 | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Medical Laboratory Technology | - |
dc.relation.journalWebOfScienceCategory | Medical Laboratory Technology | - |
dc.subject.keywordPlus | RESISTANT STAPHYLOCOCCUS-AUREUS | - |
dc.subject.keywordPlus | ANAEROBIC-BACTERIA | - |
dc.subject.keywordPlus | STRAINS | - |
dc.subject.keywordPlus | TR-700 | - |
dc.subject.keywordPlus | SUSCEPTIBILITY | - |
dc.subject.keywordPlus | SPECTRUM | - |
dc.subject.keywordAuthor | Tedizolid | - |
dc.subject.keywordAuthor | Skin | - |
dc.subject.keywordAuthor | Soft tissue | - |
dc.subject.keywordAuthor | Infection | - |
dc.subject.keywordAuthor | Pneumonia | - |
dc.subject.keywordAuthor | Gram-positive bacteria | - |
dc.identifier.url | https://www.annlabmed.org/journal/view.html?doi=10.3343/alm.2015.35.5.523 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.